Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Twist Bioscience Corporation TWST

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throu...


Recent & Breaking News (NDAQ:TWST)

Inovio Selected by CEPI to Develop Vaccine Against New Coronavirus

PR Newswire January 23, 2020

Twist Bioscience to Report Fiscal 2020 First Quarter Financial Results on Thursday, February 6, 2020

Business Wire January 23, 2020

Twist Bioscience Selected as DNA Synthesis Provider for DNA Data Storage Project Under Intelligence Advanced Research Projects Activity (IARPA) Molecular Information Storage (MIST) Program

Business Wire January 15, 2020

Twist Bioscience Announces Strategic Collaboration With Schrödinger for Drug Discovery

Business Wire January 15, 2020

Twist Bioscience Promotes Patrick Weiss to Chief Operating Officer Setting Stage for Future Growth

Business Wire January 13, 2020

Twist Bioscience to Present at the 38th Annual J.P. Morgan Healthcare Conference

Business Wire January 6, 2020

Twist Bioscience Reports Fourth Quarter and Full Year Fiscal 2019 Financial Results

Business Wire December 11, 2019

Twist Bioscience and Pandion Therapeutics Expand Antibody Optimization Collaboration

Business Wire December 11, 2019

Twist Bioscience to Report Fiscal 2019 Fourth Quarter and Full Year Financial Results on Wednesday, December 11, 2019

Business Wire November 20, 2019

Twist Bioscience Promotes Patrick J. Finn, Ph.D., to Chief Commercial Officer

Business Wire November 20, 2019

Twist Bioscience to Present at Upcoming Investor Conferences

Business Wire November 13, 2019

Twist Biopharma Implements Genedata Biologics to Advance Synthetic Biology-driven Antibody Discovery

Business Wire November 8, 2019

Twist Bioscience to Provide Target Enrichment Products for MGI in Europe and Asia Pacific

Business Wire October 30, 2019

Twist Bioscience Appoints Seasoned Life Sciences Industry Executive Nicolas M. Barthelemy to Board of Directors

Business Wire October 25, 2019

Praesens Foundation, Institut Pasteur, Institut Pasteur de Dakar, University of Nebraska Medical Center, Twist Bioscience Consortium Win Prix Galien MedStartUp Award

Business Wire October 24, 2019

Twist Bioscience Showcases Next-Generation Sequencing Products and Results at American Society for Human Genetics 2019 Annual Meeting

Business Wire October 16, 2019

Twist Bioscience Showcases New Innovation Lab at SynBioBeta 2019

Business Wire October 1, 2019

Twist Bioscience to Present at SynBioBeta 2019

Business Wire September 24, 2019

Twist Bioscience to Present at Two Investor Conferences in September

Business Wire August 30, 2019

Twist Bioscience Reports Third Quarter Fiscal 2019 Financial Results and Highlights Commercial and Operational Progress

Business Wire August 1, 2019